HemOnc Today

CURRENTLY VIEWING:

The following articles appeared in the print edition of HEMONC TODAY.

Table of Contents

American Society for Radiation Oncology members receive fellows designation

Addition of enzalutamide to androgen deprivation beneficial for certain men with prostate cancer

Fox Chase Cancer Center announces appointments

Generic oral chemotherapy less cost-effective than anticipated

ASH selects trainees, junior faculty for research training institute

Atlantic Health System Cancer Care appoints medical director of gastrointestinal medical oncology

CAR T-cell therapy approved for B-cell lymphomas may save ‘thousands of lives’ in next few years

Duvelisib extends PFS in chronic lymphocytic leukemia, small lymphocytic lymphoma

City of Hope announces two faculty appointments

Abramson Cancer Center appoints deputy director

Cover Story

Awareness, early intervention needed to reduce impact of breast cancer-related lymphedema

Editorial

The preservation of affordable cancer care

John Sweetenham, MD

FDA News

FDA approves Mylotarg for treatment of acute myeloid leukemia

FDA grants fast track designation to MitoGel for upper tract urothelial carcinoma

FDA grants orphan drug designation to SY-1425 for acute myeloid leukemia

FDA expands approval of Faslodex for advanced breast cancer

In the Journals Plus

Risk-adapted therapeutic strategies effective for early-stage Hodgkin lymphoma

Eltrombopag shows promise as first treatment for severe aplastic anemia

Percentage of uninsured, newly diagnosed patients with cancer declines after ACA

Screen-detected breast cancers persist without treatment

Blood-based assay superior to PSA for prostate cancer diagnosis

TAS-102, bevacizumab promising for refractory colorectal cancer

Meeting News

Pembrolizumab may become standard for advanced gastric cancer

Fruquintinib, gefitinib shows promise for EGFR-mutated non-small cell lung cancer

PIK3CA mutation linked to brain metastases in large cell neuroendocrine carcinoma

Medicaid expansion cuts uninsured rate by half among patients with cancer

Osimertinib extends PFS in EGFR-positive lung cancer

Palliative care, hospice resources underutilized for advanced non-small cell lung cancer

HemOnc Today New York to highlight advances in immunotherapy, targeted treatments

Ipilimumab shows promise in mutated NSCLC, but toxicities may limit use

Maintenance rucaparib extends PFS in recurrent ovarian cancer

Addition of pembrolizumab to chemotherapy improves outcomes in advanced NSCLC

Socioeconomic factors influence non-small cell lung cancer survival

Chemotherapy, radiation underused in initial treatment of limited-stage small-cell lung cancer

Survey: Breast cancer radiation therapy ‘less scary’ than anticipated

Annual CT scan does not offer survival benefit for completely resected NSCLC

Cabozantinib extends PFS as first-line therapy for metastatic renal cell carcinoma

Smoking status does not impact outcomes with anti-PD-1 therapy

Electronic medical records beneficial during lung cancer screening

Pembrolizumab shows promise in metastatic head and neck cancer

Early palliative care does not show quality-of-life benefit for newly diagnosed mesothelioma

De-escalated radiation safe, effective for HPV-positive oropharyngeal cancer

Smoking cessation counseling successfully integrates into screening program

Point/Counter

Should prophylactic antibiotic therapy be used to prevent recurrent infection in patients with lymphedema?

Supplement

CAR T-cell therapies ‘set new precedent’ in oncology

Advertisement
Advertisement